Bristol-Myers Squibb buy Bank of America Co.
Start price
27.12.23
/
50%
€46.75
Target price
27.12.24
€61.40
Performance (%)
-16.57%
Price
31.05.24
€37.90
Summary
This prediction is currently active. The prediction for Bristol-Myers Squibb disappoints with a performance of -16.57%. Dividends of €1.10 are taken into consideration when calculating the performance. This prediction currently runs until 27.12.24. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Bristol-Myers Squibb | -0.303% | -0.303% |
iShares Core DAX® | -0.552% | 3.405% |
iShares Nasdaq 100 | -1.415% | 4.613% |
iShares Nikkei 225® | -0.877% | -1.396% |
iShares S&P 500 | -0.415% | 3.338% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Bristol-Myers Squibb diskutieren
Bristol-Myers Squibb (NYSE: BMY) had its price target lowered by analysts at Bank of America Co. from $72.00 to $68.00. They now have a "buy" rating on the stock.
Ratings data for BMY provided by MarketBeat